Decreased risk of cardiovascular disease in dermatology patients taking niacinamide: A TriNetX cohort study.
- 2026-03
- Observational · n = 3,231
- Journal of the American Academy of Dermatology 94(3)
- Yousef Salem
- Mahnoor Liaqat
- Nadeen Gonna
- Dina Zamil
- Ferris Abu-Ghosh
- Anwar Merie
- Dimitri Cassimatis
- Ida Orengo
- PubMed: 41177359
- DOI: 10.1016/j.jaad.2025.10.115
- High evidence
- Clinical
Niacinamide use was associated with reduced risk of ST elevation myocardial infarction (risk ratio [RR]: 0.547, 95% confidence interval [CI]: 0.349-0.858, P = .008)
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes
- Dose
- ≥500 mg